One-year study in clinical practice
- Studiedesign
- Pragmatic clinical study with matched control group
- Population
- Children and adolescents 4–17 years in clinical obesity treatment
- Antal deltagare
- 107 patients in the intervention group, 321 in the control group
- Intervention
- Evira as an add-on to combined lifestyle treatment
- Kontrollgrupp
- Standard treatment according to the national quality register BORIS
- Uppföljningstid
- 12 months
- Utfall
- Mean change of −0.30 BMI SDS in the intervention group compared to −0.15 BMI SDS in the control group.
Hagman E, Johansson L, Kollin C, Marcus E, Drangel A, Marcus L, Marcus C, Danielsson P. International Journal of Obesity, 2022. doi: 10.1038/s41366-022-01146-8 Read the publication
Three-year follow-up of the same cohort
- Studiedesign
- Pragmatic clinical study, three-year follow-up
- Population
- Children and adolescents aged 4–17 years
- Antal deltagare
- 428 patients in total (107 with Evira, 321 in standard treatment)
- Intervention
- Evira as an add-on to combined lifestyle treatment
- Kontrollgrupp
- Conventional standard treatment
- Uppföljningstid
- 36 months
- Utfall
- The relative weight loss at one year was maintained for up to three years. A higher proportion reached below the obesity threshold, and a significantly lower proportion discontinued treatment. No patient received an eating disorder diagnosis during treatment or the subsequent year.
Hagman E, Lindberg L, Putri RR, Drangel A, Marcus C, Danielsson P. International Journal of Obesity, 2025. doi: 10.1038/s41366-025-01738-0 Read the publication
Feasibility study
- Studiedesign
- Randomised controlled feasibility study
- Population
- Children in obesity treatment at three clinics
- Antal deltagare
- Small study population, see publication
- Intervention
- Early version of Evira's platform as an add-on to ordinary treatment
- Kontrollgrupp
- Ordinary treatment
- Uppföljningstid
- 6 months
- Utfall
- Treatment effect after six months compared to ordinary treatment, as well as high satisfaction among patients and healthcare professionals.
Johansson L, Hagman E, Danielsson P. BMC Pediatrics, 2020. doi: 10.1186/s12887-020-02338-9 Read the publication
